- What dental leaders told us in May
- Climate Change: Statement on Proposed Rescission of Climate-Related Disclosure Rules
- What Gen Z’s ‘career chameleon’ era means for healthcare
- What’s going on at the FTC? 3 notes for ASC leaders
- After 3 decades at Emory, clinical exec joins Indiana University
- 8 DSOs making headlines
- The physician red flags that can predict a bad ASC partner
- The physician noncompete battle in 5 key figures
- CVS Health Ventures leads $40M investment in AI company
- Patient death draws renewed CMS scrutiny at HCA’s Mission Hospital
- The week in hospital M&A
- Patient death draws renewed CMS scrutiny at HCA’s Mission Hospital
- Nearly 70% of US counties lack a GI: 13 concerning workforce stats
- Kentucky system taps Medline as prime lab vendor
- Salina Regional seeks approval for new ASC
- Kentucky hospital names CEO
- Statement of Commissioner Mark T. Uyeda on the Rescission of Climate-Related Disclosure Rules
- Gastroenterologist named Cleveland Clinic chief of staff
- 5 joint replacement surgeons to watch
- The ‘secret sauce’ behind Northwestern Medicine’s supply chain strategy
- 10 systems seeking supply chain leaders
- Orlando Health posts 1.9% margin, sees ‘early indications’ of payer mix shift
- 6 hospitals, health systems shuttering services
- A new behavioral health profession is born
- Keynote Remarks at the 2026 Reagan National Economic Forum
- Statement on Proposing Release for Rescission of Climate-Related Disclosure Rules
- What health systems keep getting wrong about ASCs
- Dentists pay climbed the most in these 10 states
- Cardiologist wins NIH grant targeting heart failure’s hidden toll
- Mental Health Disorders Now No. 1 Cause of Disability Worldwide
- UnitedHealthcare to nix nearly two thirds of pediatric prior auths
- Industry Voices—Patients are building a new healthcare system. The industry is finally catching up
- Long COVID Might Be Twice As Common As Previously Thought
- Drug Effective In Slowing Progressive MS, Trial Shows
- Study: LA Canine Outbreak Caused By Low Vaccination Rates, Crowded Boarding
- Heavy Drinking Harms College Students' Brain Power, Study Finds
- In Vaccine-Skeptical California County, A Potential Playbook To Contain Measles
- After Her Bout of Amnesia, a $59,000 Billing Dispute Wouldn’t Go Away
- A Trump Stronghold Grapples With Health Risks of ICE Detention Sites
- Pharma urged to modernize patient support as young adult cancer rates rise
- Philips adds a spoonful of Disney sugar to ease kids’ MRI anxieties
- Aetna to launch ‘on demand’ virtual mental health services in 2027
- U of Connecticut dental school reappoints dean for 2nd term
- Michigan dentist charged with Medicaid fraud
- What’s fueling optimism for dentistry’s future
- American Academy of Pediatric Dentistry installs new president, officers
- Phase 1 Equity adds multilocation practice in Texas
- 4 key stats on the oral surgeon workforce
- Brand-name drug prices climb after launch in US, fall abroad amid MFN push: report
- Dr. Emile Rossouw appointed president of the American Board of Orthodontics
- ASCO: After Takeda’s defeat, Dizal picks up baton to take on J&J in EGFR lung cancer subtype
- Acadia in the headlines: 6 things to know
- 26 behavioral health executive moves to know
- AstraZeneca gains 2nd bladder cancer nod in key expansion for Imfinzi
- Advocate Health grows Q1 revenue by 10.8% amid higher volumes, greater efficiency
- Behavioral health hospital operator to pay $32M in Medicare fraud settlement
- Bangladesh Measles Surge Kills 500+ Children; Vaccine Delays Blamed
- Care navigation startup Garner Health banks $100M series E at $2.74B valuation
- HCA bolsters workforce pipeline with healthcare professional college acquisition
- Plant-Based Diet May Cut Obesity Risk For Women In Menopause
- Pharma leaders meet with PM Takaichi in push for Japan to retain R&D edge
- Penn Medicine, K Health partner to deploy AI clinical agents
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CMS finalizes changes to No Surprises Act dispute resolution process
- Smartwatch App Accurately Detects Major Epileptic Seizures
- Racial Gap Exists For Asthma Inhaler Use
- New Colon Cancer Screening Guidelines Add Blood And At-Home Tests
- Fierce Pharma Asia—More China biotech hawkishness; Pfizer’s $10B Innovent deal; Astellas’ roadmap
- CVS expands partnership with Salesforce for greater call center personalization
- Nurse Convicted In Patient's Death Turns Fatal Drug Error Into Cautionary Tale
- Wearable Ultrasound Patch Monitors High-Risk Pregnancies In Real Time
- In a Vaccine-Skeptical California County, a Potential Playbook To Contain Measles
- Listen to the Latest ‘KFF Health News Minute’
- Teladoc Health inks partnership with Walmart to expand virtual care services
- PharmaEssentia taps Incyte alum Eric Vogel as it eyes Besremi expansion
- Kaléo speaks up on allergy awareness to amplify patient stories
- Privacy and PetShops: Remarks at the Regulatory PETshop Series: Cryptographic Technologies and Financial Services Regulation
- NYC Health + Hospitals adds 2nd behavioral health housing site
- Mindfulness isn’t a perk anymore — it’s a workforce strategy
- ‘Standardize what protects the patient’: The balancing act in behavioral healthcare operations
- With Elahere building steam, AbbVie nets FDA nod for another ImmunoGen cancer asset
- Nebraska behavioral health workforce grew 49% since 2010: 4 notes
- Hospitals again ask FTC, DOJ for exemption from expanded premerger notification filings
- Coalition for Health AI unveils governance playbooks for responsible AI adoption
- Amazon taps Roy Schoenberg to lead healthcare business as Neil Lindsay plans to step down
- Viridian, awaiting FDA decision, taps WuXi Bio in eye drug supply deal
- U.S. To Keep Ebola-Exposed Citizens In Kenya Under New Policy
- CAT on a Hot Tin Roof
- GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers
- GoodRx launches subscription program for low-cost generic medications, telehealth services
- George Washington University locks deal to hand off debt-ridden physician practice to UHS
- Humana invests $83M in new Florida pharmacy distribution center
- As J&J separates from its orthopedics business, it's laying off 56 employees in New Jersey
- ASCO preview: With expectations jacked up, Akeso's ivonescimab to face scrutiny in high-stakes plenary
- An insider’s look at LillyDirect
- GLP-1 manufacturer CordenPharma strikes deal for peptide CDMO, lining up new production sites in US and China
- Weight-Loss Program Helps Women Battling Breast Cancer
- Younger U.S. Women of Color Face Rising Breast Cancer Deaths
- High Fitness Doesn’t Raise A-fib Risk In Young Men, Study Finds
- Cheaper, Alternative Health Plans Are Having A Moment, But Critics Urge Caution
- Ultrafine Wildfire Smoke Particles May Pose Serious Health Risks
- Montana Hurries To Adopt Trump’s Medicaid Work Rules Amid Budget Woes
- Nurse Convicted in Patient’s Death Turns Fatal Drug Error Into a Cautionary Tale
- Readers Address Drugged Driving, Suicide Prevention, Worker Shortages
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Biogen investigated by Italian regulator over multiple sclerosis ‘market abuse’ claims
- FDA delays ruling on AstraZeneca’s breast cancer drug after negative adcomm vote
- Eli Lilly wins argument over Noom’s GLP-1 dosing claims
- Remarks at the Stanford Rock Center for Corporate Governance
- Smart ring maker Oura files confidentially for IPO as consumer demand propels revenue growth
- Outlook moves toward potential US nod for thrice-snubbed eye drug with FDA appeal win
- JD Power: Cost pressures worsen member experience with commercial plans
- Trinity Health credits pay rates, cost management for its steady 1% operating margin
- Trump Admin Bars Key U.S. Researchers From Global Virus Response Talk
- Listen to the Latest ‘KFF Health News Minute’
- As calls for COINS Act expansion grow, will new rules sweep up China biotech licensing?
- CVS sues to challenge Tennessee's new PBM law
- Radiopharmaceutical outfit Lantheus mulls potential $7B takeover by Curium: Bloomberg
- Everyone Has A Family Doc, But Can You Get An Appointment?
- Many U.S. College Students With Psychosis Are Not Receiving Treatment
- Antibiotics Won't Help Ease Asthma-Linked Wheezing in Kids
- Yoga Eases Insomnia And Anxiety In Cancer Survivors, Study Finds
- SK bioscience links up with Colombia to enable local production of varicella vaccine
- After prior FDA manufacturing snub, Gilead's hepatitis D med Hepcludex nabs US nod
- Dust Yields Clues to Viral Outbreaks, Study Finds
- 3 Medical Routines That Older People May Not Need
- Cheaper, Alternative Health Plans Are Having a Moment, but Critics Urge Caution
- Wheel, b.well partner to build turnkey infrastructure behind AI-native virtual care
- Journalists Distill News on Ebola, Licensing Midwives, and California’s Budget
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Severe Asthma Often Comes With Other Serious Health Problems
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Common Food Preservatives Linked to Major Heart Problems
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fatty Liver Disease Increases Heart Attack Risk, Study Says
- Religious Anti-Abortion Center Finds Opportunity In Town Without OB-GYNs
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Statement on Novel Exchange-Traded Funds (ETFs)
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
Erica G. Schwartz is a retired rear admiral in the U.S. Public Health Service Commissioned Corps who was Deputy Surgeon General from January 2019 to April 2021:
Trump nominates former deputy surgeon general as CDC director
By Yasmeen Abutaleb and Julie Steenhuysen - April 16, 2026Summary
- Position has been open since Susan Monarez was fired last year
- Schwartz has been praised by former public health officials
- Nominated healthcare executive Sean Slovenski as deputy director
WASHINGTON, April 16 (Reuters) - U.S. President Donald Trump said on Thursday he would nominate Erica Schwartz, who had served as deputy surgeon general during the COVID-19 pandemic, to become director of the Centers for Disease Control and Prevention following multiple leadership shakeups at the health agency.
Schwartz, who served during Trump's first term, was involved in the federal COVID response, helping to coordinate national preparedness and public health efforts.
The nomination represents a far more traditional pick for the embattled health agency, as the White House seeks to focus on more popular issues such as lowering drug prices and food safety, rather than Health Secretary Robert F. Kennedy Jr.'s controversial vaccine policies with Republicans bracing for a difficult November midterm election. At a pair of congressional hearings on Thursday, Kennedy largely avoided questions about vaccines.
Trump, in a post on Truth Social, also said he was naming healthcare executive Sean Slovenski as CDC deputy director and chief operating officer, Texas Health Commissioner Jen Shuford as CDC deputy director and chief medical officer and FDA official Sara Brenner as senior counselor for public health to Kennedy.
The nominations come after a Massachusetts judge blocked key parts of Kennedy's effort to reshape U.S. vaccine policy, including a move to reduce the number of shots routinely recommended for children, and his overhaul of a CDC advisory committee on inoculations.
If approved, Schwartz would lead the Atlanta-based agency, which tracks and responds to domestic and foreign threats to public health. The CDC director traditionally has the final say on U.S. vaccine policy.
She would report to Kennedy, who has long questioned the safety of vaccines, contrary to established science.
Trump fired CDC Director Susan Monarez last August over her objections to vaccine policy changes planned by Kennedy. Her position was filled by two acting directors: Health and Human Services Deputy Secretary Jim O'Neill, who was succeeded in February by Jay Bhattacharya, the director of the U.S. National Institutes of Health.
MORE TRADITIONAL CANDIDATES
Schwartz, who does not have a widely publicized position on vaccines, has been praised by former public health officials who have been critical of Kennedy's vaccine policies.
Demetre Daskalakis, former CDC director of the National Center for Immunization and Respiratory Diseases who resigned after Monarez's firing, said Schwartz showed "good leadership" during the COVID response and has a "proven track record... notably with pandemic preparedness."
Polls have shown most voters disapprove of Kennedy's moves to overhaul the childhood vaccination schedule.
The White House has pushed for more traditional candidates for top agency roles after Kennedy handpicked a slate of controversial political appointees who have undermined trust in vaccines, according to sources familiar with the discussions.
Close Kennedy ally and vaccine injury lawyer Aaron Siri was critical of the nomination.
"Her long track record of directly issuing rights-crushing civilian and military vaccine mandates, including mandating injection of smallpox, anthrax, and flu vaccines into U.S. Forces, and disciplining those that refused, reflects she lacks the basic ethics and morals to lead the CDC," Siri said. "This agency does not need another cheerleader for industry."
The Erica Schwartz nomination was actually Secretary Kennedy's:
https://thehill.com/policy/healthcare/5841154-kennedy-trump-cdc-nominee/
RFK Jr. says he did not speak to Trump about CDC nominee
By Nathaniel Weixel - April 21, 2026Health Secretary Robert F. Kennedy Jr. did not speak to President Trump about nominating Erica Schwartz to lead the Centers for Disease Control and Prevention, he told lawmakers Tuesday.
Kennedy told a House Energy and Commerce subcommittee that he met with Schwartz on “multiple occasions” prior to her being tapped as the new nominee, including to discuss her views on vaccinations.
But Kennedy said it was HHS chief counselor Chris Klomp who spoke with Trump about the nomination. He also said HHS suggested Schwartz as a candidate to the White House.
Klomp was elevated to the agency’s No. 2 spot in February, reportedly to help the White House instill a stabilizing force and message discipline at HHS ahead of the midterm elections.
Schwartz, who served as deputy surgeon general during the first Trump administration and spent much of her career in health roles in the U.S. military, has no public ties to the anti-vaccine movement.
Public health leaders and advocates breathed sighs of relief when Trump announced her as the nominee late last week, and her nomination was seen as a clear sign that the administration is putting pressure on Kennedy to sideline his controversial vaccine policies due to political concerns in an election year.
But there is concern that Schwartz will need to be granted full autonomy from Kennedy to succeed in steadying the CDC and reinforcing its reputation as the leading scientific and public health agency.
Her predecessor, Susan Monarez, boasted similar public health credentials but was fired after less than a month on the job because she clashed with Kennedy over vaccine moves.
Under questioning from Rep. Raul Ruiz (D-Calif.), Kennedy declined to commit to implementing any vaccine guidance issued by Schwartz.
“You’ll probably fire her” like Monarez, Ruiz said, “because you will not accept recommendations based on science.”
Kennedy then denied he had been sidelined by the White House.
“That’s not true,” Kennedy said. “You’re not getting truths.”
“How does that make you feel, Mr. Secretary?” Ruiz continued. “You must be aware of that. It must be nerve-wracking, especially after AG [Pam] Bondi, and Secretaries [Kristi] Noem and [Lori] Chavez-Deremer were fired for making the president look bad.”
“You’re making stuff up,” Kennedy shot back.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
















